Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kalijn Fredrike Bol"'
Autor:
Sofie Kirial Mørk, Mohammad Kadivar, Kalijn Fredrike Bol, Arianna Draghi, Marie Christine Wulff Westergaard, Signe Koggersbøl Skadborg, Nana Overgaard, Anders Bundgård Sørensen, Ida Svahn Rasmussen, Lars Vibe Andreasen, Christina Westmose Yde, Thomas Trolle, Christian Garde, Jens Friis-Nielsen, Nis Nørgaard, Dennis Christensen, Jens Vindahl Kringelum, Marco Donia, Sine Reker Hadrup, Inge Marie Svane
Publikováno v:
OncoImmunology, Vol 11, Iss 1 (2022)
The majority of neoantigens arise from unique mutations that are not shared between individual patients, making neoantigen-directed immunotherapy a fully personalized treatment approach. Novel technical advances in next-generation sequencing of tumor
Externí odkaz:
https://doaj.org/article/7abb393630304338a7037f295b6ab061
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 15, p 5231 (2020)
Melanoma of the ocular region (ocular melanoma) comprises about 5% of all patients with melanoma and covers posterior uveal melanoma, iris melanoma, and conjunctival melanoma. The risk of metastasis is much higher in patients with ocular melanoma com
Externí odkaz:
https://doaj.org/article/c20953a5611b417f9e481f3e6cd9be6b
Autor:
Rikke Andersen, István Csabai, Krisztián Papp, Özcan Met, Martin Lauss, Aishwarya Gokuldass, Morten Nielsen, Kalijn Fredrike Bol, Inge Marie Svane, Zoltan Szallasi, Marie Christine Wulff Westergaard, Marco Donia, Katja Harbst, Mario Presti, Aimilia Schina, Christopher Aled Chamberlain, Troels Holz Borch, Göran Jönsson, Arianna Draghi, Samuele Soraggi
Publikováno v:
Cancers
Gokuldass, A, Draghi, A, Papp, K, Borch, T, Nielsen, M, Wulff Westergaard, M C, Andersen, R, Schina, A, Bol, K F, Chamberlain, C A, Presti, M, Met, Ö, Harbst, K, Lauss, M, Soraggi, S, Csabai, I, Szallasi, Z, Jönsson, G, Svane, I M & Donia, M 2020, ' Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8 + T Cells in Non-Melanoma Cancers Compared to Melanoma ', Cancers, vol. 12, no. 11, 3344 . https://doi.org/10.3390/cancers12113344
Gokuldass, A, Draghi, A, Papp, K, Borch, T H, Nielsen, M, Westergaard, M C W, Andersen, R, Schina, A, Bol, K F, Chamberlain, C A, Presti, M, Met, Ö, Harbst, K, Lauss, M, Soraggi, S, Csabai, I, Szállási, Z, Jönsson, G, Svane, I M & Donia, M 2020, ' Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8 + T cells in non-melanoma cancers compared to melanoma ', Cancers, vol. 12, no. 11, 3344, pp. 1-15 . https://doi.org/10.3390/cancers12113344
Volume 12
Issue 11
Cancers, Vol 12, Iss 3344, p 3344 (2020)
Gokuldass, A, Draghi, A, Papp, K, Borch, T, Nielsen, M, Wulff Westergaard, M C, Andersen, R, Schina, A, Bol, K F, Chamberlain, C A, Presti, M, Met, Ö, Harbst, K, Lauss, M, Soraggi, S, Csabai, I, Szallasi, Z, Jönsson, G, Svane, I M & Donia, M 2020, ' Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8 + T Cells in Non-Melanoma Cancers Compared to Melanoma ', Cancers, vol. 12, no. 11, 3344 . https://doi.org/10.3390/cancers12113344
Gokuldass, A, Draghi, A, Papp, K, Borch, T H, Nielsen, M, Westergaard, M C W, Andersen, R, Schina, A, Bol, K F, Chamberlain, C A, Presti, M, Met, Ö, Harbst, K, Lauss, M, Soraggi, S, Csabai, I, Szállási, Z, Jönsson, G, Svane, I M & Donia, M 2020, ' Qualitative analysis of tumor-infiltrating lymphocytes across human tumor types reveals a higher proportion of bystander CD8 + T cells in non-melanoma cancers compared to melanoma ', Cancers, vol. 12, no. 11, 3344, pp. 1-15 . https://doi.org/10.3390/cancers12113344
Volume 12
Issue 11
Cancers, Vol 12, Iss 3344, p 3344 (2020)
Simple Summary Human tumors are often infiltrated by T cells; however, it remains unclear what proportion of T cells infiltrating tumors are bystander and non-tumor specific. We have investigated qualitative characteristics of these tumor-infiltratin
Publikováno v:
Bol, K F, Donia, M, Heegaard, S, Kiilgaard, J F & Svane, I M 2020, ' Genetic biomarkers in melanoma of the ocular region : What the medical oncologist should know ', International Journal of Molecular Sciences, vol. 21, no. 15, 5231, pp. 1-14 . https://doi.org/10.3390/ijms21155231
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 5231, p 5231 (2020)
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 5231, p 5231 (2020)
Melanoma of the ocular region (ocular melanoma) comprises about 5% of all patients with melanoma and covers posterior uveal melanoma, iris melanoma, and conjunctival melanoma. The risk of metastasis is much higher in patients with ocular melanoma com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bc7b5a88e6415f4f38b921a85663876
https://curis.ku.dk/ws/files/256216965/ijms_21_05231_v2.pdf
https://curis.ku.dk/ws/files/256216965/ijms_21_05231_v2.pdf
Autor:
Marco Donia, Inge Marie Svane, Lars Bastholt, Jens Folke Kiilgaard, Kalijn Fredrike Bol, Henrik Schmidt, Eva Ellebaek
Publikováno v:
Bol, K F, Ellebaek, E, Donia, M, Schmidt, H, Bastholt, L, Kiilgaard, J F & Svane, I-M 2019, ' Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma ', Annals of Oncology, vol. 30, no. Suppl. 5, 1322P, pp. 539 . https://doi.org/10.1093/annonc/mdz255.011
Background Uveal melanoma (UM) is the most common intraocular malignancy. The disease is clinically and genetically distinct from cutaneous melanoma and shows a high rate of metastatic spread. As randomized clinical trials with immune checkpoint inhi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f5895eac573b2e280d91b7092236dd7
https://portal.findresearcher.sdu.dk/da/publications/a28da139-500b-492d-a5f6-e5f6cd721dfa
https://portal.findresearcher.sdu.dk/da/publications/a28da139-500b-492d-a5f6-e5f6cd721dfa
Autor:
Lise Hoejberg, Lars Bastholt, Marco Donia, Kalijn Fredrike Bol, Inge Marie Svane, Ulrich Heide Køhler, Jens Folke Kiilgaard, Tobias Wirenfeldt Klausen, Eva Ellebaek, Mathilde Skaarup Larsen, Henrik Schmidt, Mette Bagger
Publikováno v:
Bol, K F, Ellebaek, E, Hoejberg, L, Bagger, M M, Larsen, M S, Klausen, T W, Køhler, U H, Schmidt, H, Bastholt, L, Kiilgaard, J F, Donia, M & Svane, I M 2019, ' Real-world impact of immune checkpoint inhibitors in metastatic uveal melanoma ', Cancers, vol. 11, no. 10, 1489 . https://doi.org/10.3390/cancers11101489
Cancers
Volume 11
Issue 10
Bol, K F, Ellebaek, E, Hoejberg, L, Bagger, M M, Larsen, M S, Klausen, T W, Køhler, U H, Schmidt, H, Bastholt, L, Kiilgaard, J F, Donia, M & Svane, I M 2019, ' Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma ', Cancers, vol. 11, no. 10, 1489; . https://doi.org/10.3390/cancers11101489
Cancers, Vol 11, Iss 10, p 1489 (2019)
Cancers
Volume 11
Issue 10
Bol, K F, Ellebaek, E, Hoejberg, L, Bagger, M M, Larsen, M S, Klausen, T W, Køhler, U H, Schmidt, H, Bastholt, L, Kiilgaard, J F, Donia, M & Svane, I M 2019, ' Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma ', Cancers, vol. 11, no. 10, 1489; . https://doi.org/10.3390/cancers11101489
Cancers, Vol 11, Iss 10, p 1489 (2019)
Uveal melanoma (UM) is the most common intraocular malignancy in adults and shows a high rate of metastatic spread. As randomized clinical trials with immune checkpoint inhibitors (ICI) have not been performed in patients with metastatic UM, we analy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eb2aaa6642e5a38df4f9699fed4653f
https://pure.au.dk/portal/da/publications/realworld-impact-of-immune-checkpoint-inhibitors-in-metastatic-uveal-melanoma(a32906ce-fc75-41e0-8c34-7bc6d9ceb84b).html
https://pure.au.dk/portal/da/publications/realworld-impact-of-immune-checkpoint-inhibitors-in-metastatic-uveal-melanoma(a32906ce-fc75-41e0-8c34-7bc6d9ceb84b).html
Autor:
Lars Vibe Andreasen, T. Bogenrieder, Mohammad Kadivar, J.V. Kringelum, S. Reker Hadrup, B. Rønø, I.M. Svane, Dennis Christensen, Nadia Viborg Petersen, S.S. Hernandez, Marco Donia, S.K. Moerk, Arianna Draghi, P.L. Andersen, A.B. Sorensen, Kalijn Fredrike Bol
Publikováno v:
Annals of Oncology. 30:xi41
Background The majority of neoantigens arise from unique mutations which are not shared between individual patients. Thus, neoantigen-directed immunotherapy is a fully personalized treatment. Novel technical advances in next-generation sequencing and